2022/08/22(月)
[Keynote 1] LabCentral/BioLabs
Profile
Dr. Fruehauf is a biotechnology entrepreneur and investor with a track record of building and growing successful companies.
He is a physician-scientist experienced in the development of complex biologics programs from bench into the clinic, including the first oral RNAi drug to enter the clinic. Co-founder and general partner at BioInnovation Capital, now MissionBioCapital.
Founder/Co-founder of LabCentral, Cambridge Biolabs, BioLabs North Carolina, Philadelphia, San Diego, New York, Princeton, Tufts, Los Angeles; BioInnovation Capital, ViThera, Cequent, German Life Science Accelerator.